In late 2022, SkinStasis Skin Care introduced NextLeap™, an innovative treatment that redefines cold sore care by offering a rapid, effective “cosmetic” solution – one that goes beyond simple cover-up solutions. Powered by Tranexamic Acid (TXA), a proven ingredient in skincare, NextLeap™ is designed to target discoloration and redness, delivering visible improvements within 1-2 days when applied at the first symptom (the first tingling sensation).
This ground-breaking product provides a fresh perspective in cold sore care, focusing on rapid aesthetic recovery and setting a new industry standard. Unlike traditional, outdated treatments that offer minimal results, NextLeap™ claims to deliver a faster, more targeted solution for those seeking rapid visible improvement.
Tranexamic Acid (TXA): The Science behind the Innovation
Tranexamic Acid (TXA) is a synthetic analog of the amino acid lysine, which has been used for over four decades to treat skin conditions like melasma and hyperpigmentation. While its precise mechanism isn’t fully understood, TXA is believed to inhibit melanin production, helping reduce discoloration. Additionally, TXA can calm inflammation, making it effective for conditions like rosacea and post-inflammatory hyperpigmentation. Given these properties, TXA offers a promising new approach for cold sore treatment.
A Shift Away from Traditional Outdated Treatments
Docosanol, an active ingredient in many popular cold sore treatments, was approved by the FDA 25 years ago isn’t actually an antiviral. Instead of targeting the herpes simplex virus (HSV-1) directly, it works by blocking the virus from entering cells, potentially reducing the duration of a cold sore outbreak. Acyclovir and valacyclovir focus on reducing viral replication to shorten the duration of outbreaks. However, numerous surveys have shown that the benefits of these treatments are often modest and, for many, barely noticeable. They also fail to address the cosmetic effects of cold sores, leaving users with lingering discoloration or scars.
NextLeap™ stands apart by targeting the visible effects of cold sores, helping users recover faster and return to a normal skin appearance in just 1-2 days (as claimed by the company). By addressing both the aesthetic impact and rapid recovery of cold sore outbreaks, NextLeap™ offers a refreshing alternative to outdated solutions that deliver minimal visible results.
Key Benefits of NextLeap™
- Cosmetic Focus: NextLeap™ focuses on the cosmetic effects of cold sores, reducing dark spots and discoloration following an outbreak.
- Use at First Symptom: Applied at the first tingling or itching sensation, NextLeap™ promises a rapid return to normal skin appearance, with visible results in as little as 1-2 days.
- Tranexamic Acid (TXA): TXA’s ability to reduce skin discoloration and redness makes it a game-changer for those struggling with the lasting cosmetic effects of cold sores.
A New Era in Cold Sore Management
Cold sores cause both physical discomfort and emotional distress due to their visible impact. Traditional, outdated treatments often offer modest results that many find barely noticeable. NextLeap™ claims to provide a fresh alternative by targeting the cosmetic effects of cold sores and promoting rapid recovery.
With its innovative approach and proven ingredients, NextLeap™ represents a leap forward in cold sore care, offering a rapid and effective cosmetic solution for those seeking not just relief, but visible improvement.